Description
E014042 - BLOOD AND BLOOD PRODUCTS
First action · last action
2026-08-25 · 2026-08-25
Transactions
1
First transaction's obligation
$2,500
Base + all options value (sum of deltas)
$2,500
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I))
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
36C25221A0024
NAICS
325414 · BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-08-25+$2,500= $2,500
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-08-25 | +$2,500 | $2,500 | E014042 - BLOOD AND BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI G69LHXJ3ABL5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25226N0549 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $170 | FY2026 |
| 36C25226N0551 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $2,100 | FY2026 |
| 36C25226N0548 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $10,000 | FY2026 |
| 36C25026P0816 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $19,329 | FY2026 |
| 36C24126N0603 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $1,998,719 | FY2026 |
| 36C25026N0624 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6506 · BLOOD AND BLOOD PRODUCTS | $948,509 | FY2026 |
Other recipients under 6505 from 252-NETWORK CONTRACT OFFICE 12 (36C252) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25226N0450 | BOSTON SCIENTIFIC CORP | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $607,804 | FY2026 |
| 36C25226N0475 | VIFOR (INTERNATIONAL) AG | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $3,546 | FY2026 |
| 36C25226P0445 | ACCREDO HEALTH GROUP, INC | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $349,099 | FY2026 |
| 36C25226N0456 | MEDI-PHYSICS, INC. | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $34,735 | FY2026 |
| 36C25226F0318 | CSL BEHRING L.L.C. | 252-NETWORK CONTRACT OFFICE 12 (36C252) | $85,484 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25226N0550_3600_36C25221A0024_3600 · retrieved 2026-09-26.